Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study. - Archive ouverte HAL Accéder directement au contenu
Autre Publication Scientifique Année : 2015

Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.

Résumé

The prognosis of advanced epithelial ovarian cancer remains poor. The current treatment is the association of complete macroscopic cytoreductive surgery and platinum-based chemotherapy. It is accepted that the absence of residual disease after surgery is a key to improve prognosis. 60 % of patients treated by complete cytoreductive surgery and chemotherapy will develop peritoneal recurrence.

Domaines

Cancer
Fichier principal
Vignette du fichier
AZAIS-SCHMITT-TARDIVEL-KERDRAON-STALLIVIERI-FROCHOT-BETROUNI-COLLINET-MORDON-04082015101111.pdf (12.4 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01183340 , version 1 (07-08-2015)

Identifiants

  • HAL Id : hal-01183340 , version 1

Citer

Henri Azais, Caroline Schmitt, Meryem Tardivel, Olivier Kerdraon, Aurélie Stallivieri, et al.. Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study. . 2015. ⟨hal-01183340⟩
122 Consultations
231 Téléchargements

Partager

Gmail Facebook X LinkedIn More